BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18615640)

  • 1. High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells.
    Widmer M; Hanemann CO; Zajicek J
    J Neurosci Res; 2008 Nov; 86(14):3212-20. PubMed ID: 18615640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptors in human astroglial tumors.
    Held-Feindt J; Dörner L; Sahan G; Mehdorn HM; Mentlein R
    J Neurochem; 2006 Aug; 98(3):886-93. PubMed ID: 16893424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis.
    Lorente M; Carracedo A; Torres S; Natali F; Egia A; Hernández-Tiedra S; Salazar M; Blázquez C; Guzmán M; Velasco G
    Glia; 2009 Oct; 57(13):1374-85. PubMed ID: 19229996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids.
    Carracedo A; Geelen MJ; Diez M; Hanada K; Guzmán M; Velasco G
    Biochem J; 2004 Jun; 380(Pt 2):435-40. PubMed ID: 14979873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta(9)-Tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling.
    Takeda S; Yamaori S; Motoya E; Matsunaga T; Kimura T; Yamamoto I; Watanabe K
    Toxicology; 2008 Mar; 245(1-2):141-6. PubMed ID: 18249480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.
    Galanti G; Fisher T; Kventsel I; Shoham J; Gallily R; Mechoulam R; Lavie G; Amariglio N; Rechavi G; Toren A
    Acta Oncol; 2008; 47(6):1062-70. PubMed ID: 17934890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.
    Caffarel MM; Sarrió D; Palacios J; Guzmán M; Sánchez C
    Cancer Res; 2006 Jul; 66(13):6615-21. PubMed ID: 16818634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesis: cannabinoid therapy for the treatment of gliomas?
    Velasco G; Galve-Roperh I; Sánchez C; Blázquez C; Guzmán M
    Neuropharmacology; 2004 Sep; 47(3):315-23. PubMed ID: 15275820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids.
    Börner C; Höllt V; Sebald W; Kraus J
    J Leukoc Biol; 2007 Jan; 81(1):336-43. PubMed ID: 17041005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.
    Massi P; Vaccani A; Ceruti S; Colombo A; Abbracchio MP; Parolaro D
    J Pharmacol Exp Ther; 2004 Mar; 308(3):838-45. PubMed ID: 14617682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
    Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
    Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid signaling in glioma cells.
    Ellert-Miklaszewska A; Ciechomska I; Kaminska B
    Adv Exp Med Biol; 2013; 986():209-20. PubMed ID: 22879071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration.
    Leelawat S; Leelawat K; Narong S; Matangkasombut O
    Cancer Invest; 2010 May; 28(4):357-63. PubMed ID: 19916793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages.
    Tolón RM; Núñez E; Pazos MR; Benito C; Castillo AI; Martínez-Orgado JA; Romero J
    Brain Res; 2009 Aug; 1283():148-54. PubMed ID: 19505450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
    Kalia VK; Prabhakara S; Narayanan V
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids and ceramide: two lipids acting hand-by-hand.
    Velasco G; Galve-Roperh I; Sánchez C; Blázquez C; Haro A; Guzmán M
    Life Sci; 2005 Aug; 77(14):1723-31. PubMed ID: 15958274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of annexin 2 decreases migration of human glioma cells in vitro.
    Tatenhorst L; Rescher U; Gerke V; Paulus W
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):271-7. PubMed ID: 16640645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids and gastrointestinal motility: animal and human studies.
    Aviello G; Romano B; Izzo AA
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():81-93. PubMed ID: 18924447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells.
    Caffarel MM; Moreno-Bueno G; Cerutti C; Palacios J; Guzman M; Mechta-Grigoriou F; Sanchez C
    Oncogene; 2008 Aug; 27(37):5033-44. PubMed ID: 18454173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid signalling in the enteric nervous system.
    Galligan JJ
    Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.